Medpace Holdings (MEDP) Net Cash Flow (2015 - 2026)

Medpace Holdings (MEDP) has reported Net Cash Flow for 12 consecutive years, with -$150.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow rose 62.26% year-over-year to -$150.2 million; the trailing twelve-month figure through Jun 2026 stood at $457.4 million (up 197.56% YoY), and the FY2025 full-year result was -$178.3 million, down 141.81% from the prior year.
• Net Cash Flow fell to -$150.2 million in Q2 2026 per MEDP's latest filing, from $157.7 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $239.0 million in Q3 2025 and bottomed at -$398.1 million in Q2 2025.
• Historically, Net Cash Flow has averaged $2.5 million across 5 years, with a median of $16.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow slumped 764.14% in 2022, then jumped 4199.56% in 2023.
• Over 5 years, Net Cash Flow stood at -$3.7 million in 2022, then surged by 4199.56% to $149.9 million in 2023, then tumbled by 90.33% to $14.5 million in 2024, then soared by 1355.04% to $210.9 million in 2025, then sank by 171.22% to -$150.2 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$150.2 million, $157.7 million, and $210.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.